Royalty Pharma's Q3 Attributable Net Income Declines, Revenue Increases
MT newswire2026/11/04 11:17Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
07:17 AM EST, 11/04/2026 (MT Newswires) -- Royalty Pharma (RPRX) reported Q3 attributable net income of $145 million, down from $284 million a year earlier. Total income and other revenue for the quarter ended Sept. 30 stood at $690 million, compared with $609 million a year earlier. Analysts' estimates were unavailable for comparison.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Wedbush lowers the target price for Cerebras Systems to $190.
格隆汇•2026/11/09 12:36
BUZZ-Zura Bio shares plummet after mid-stage trial failure of skin disease drug
路透 社•2026/11/09 12:31
Netcapital Gets Nasdaq Extension Until Feb. 9 to File Overdue Reports
Bitget•2026/11/09 12:30
Crypto prices
More
Bitcoin
BTC
$74,804.4
-1.37%
Ethereum
ETH
$2,125.27
-4.93%
Tether USDt
USDT
$0.9987
+0.01%
BNB
BNB
$685.8
-1.69%
USDC
USDC
$0.9998
+0.01%
XRP
XRP
$1.1
-4.91%
Solana
SOL
$86.65
-3.05%
TRON
TRX
$0.3174
-0.90%
Zcash
ZEC
$1,217.49
-3.89%
Hyperliquid
HYPE
$73.68
-4.66%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now